drugset / Trial / NCT01950403
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers
RandomizedParallel-groupDouble-blindBasic science
Summary
This randomized phase I trial studies the side effects and best dose of linaclotide acetate in preventing colorectal cancer in healthy volunteers. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of linaclotide acetate may prevent colorectal cancer.
Timeline
- Start
- 2013-09
- Primary completion
- 2016-04-28
- Completion
- 2018-02-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linaclotide | Peptide | 0.87 mg | Oral |